Beata Smolarz
Overview
Explore the profile of Beata Smolarz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
126
Citations
1089
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Smolarz B, Lukasiewicz H, Samulak D, Piekarska E, Kolacinski R, Romanowicz H
Int J Mol Sci
. 2025 Mar;
26(5).
PMID: 40076671
Lung cancer is one of the most common malignant cancers in most countries and is the leading cause of death among cancer diseases worldwide. Despite constant progress in diagnosis and...
2.
Jablonska K, Kmiecik A, Nowinska K, Piotrowska A, Suchanski J, Ratajczak-Wielgomas K, et al.
Int J Mol Sci
. 2025 Feb;
26(4).
PMID: 40003884
Breast cancer (BC) is the most common cancer in women, and a higher level of prolactin-induced protein (PIP) is associated with better responses to adjuvant chemotherapy. The signal transducer and...
3.
Sychowski G, Romanowicz H, Smolarz B
Int J Mol Sci
. 2025 Jan;
26(2).
PMID: 39859370
Breast cancer is one of the most common cancers diagnosed in both countries with high and low levels of socio-academic development. Routine, regular screening tests being introduced in an increasing...
4.
Olbromski M, Mrozowska M, Smolarz B, Romanowicz H, Rusak A, Piotrowska A
Sci Rep
. 2024 Nov;
14(1):26935.
PMID: 39505971
Breast cancer (BC) is the leading cause of death among cancer patients worldwide. In 2020, almost 12% of all cancers were diagnosed with BC. Therefore, it is important to search...
5.
Gornicki T, Lambrinow J, Mrozowska M, Krawczynska K, Staszko N, Kmiecik A, et al.
Cells
. 2024 Sep;
13(18.
PMID: 39329736
Epithelial-to-mesenchymal transition (EMT) is a complex cellular process that allows cells to change their phenotype from epithelial to mesenchymal-like. Type 3 EMT occurs during cancer progression. The aim of this...
6.
Smolarz B, Lukasiewicz H, Samulak D, Kolacinski R, Langner S, Makowska M, et al.
Anticancer Res
. 2024 Aug;
44(9):3697-3712.
PMID: 39197887
The transcription factor hypoxia inducible factor-1 (HIF-1) is one of the main factors in the cell's response to a lack of oxygen. Hypoxia is a typical feature of a growing...
7.
Smolarz B, Nowak A, Brys M, Forma E, Lukasiewicz H, Samulak D, et al.
In Vivo
. 2024 Aug;
38(5):2134-2143.
PMID: 39187368
Background/aim: The aim of this study was to analyze rs2234693 and rs9340799 polymorphisms of the ESR1 gene in the context of breast cancer risk in Polish patients. Materials And Methods:...
8.
Olbromski M, Mrozowska M, Piotrowska A, Kmiecik A, Smolarz B, Romanowicz H, et al.
Am J Cancer Res
. 2024 Jul;
14(6):3036-3058.
PMID: 39005669
Cancer is the leading cause of death worldwide. The World Health Organization (WHO) estimates that 10 million fatalities occurred in 2023. Breast cancer (BC) ranked first among malignancies with 2.26...
9.
Olbromski M, Mrozowska M, Piotrowska A, Smolarz B, Romanowicz H
Cancer Immunol Immunother
. 2024 Jun;
73(8):136.
PMID: 38833004
A checkpoint protein called the V-domain Ig suppressor of T cell activation (VISTA) is important for controlling immune responses. Immune cells that interact with VISTA have molecules, or receptors, known...
10.
Smolarz B, Szaflik T, Romanowicz H, Brys M, Forma E, Szyllo K
Int J Mol Sci
. 2024 May;
25(10).
PMID: 38791310
The coordinated action of VEGF, IGF1/2 and H19 factors influences the development of endometriosis. The aim of this study was to analyze the expression level of these genes in patients...